Grove Biopharma

Grove Biopharma is a biotechnology company developing novel therapies using its Bionic Biologics™ platform, which targets previously intractable intracellular disease targets. This platform integrates biologic and synthetic design principles to create cell-penetrant molecules that inhibit or degrade challenging intracellular targets. The company's initial focus is on oncology and neurodegenerative diseases.


Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $30M

Date: 23-Apr-2025

Investors: DCVC Bio, Eli Lilly and Company, InVivium Capital, Walder Ventures, Gradiant Corporation, Mansueto Investments, Portal Innovations

Markets: Biotechnology, Oncology, Neurodegenerative Diseases

HQ: Chicago, Illinois, United States

Founded: 2020

Website: https://grovebiopharma.com/

LinkedIn: https://www.linkedin.com/company/grove-biopharma-inc

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/grove-biopharma

Pitchbook: https://pitchbook.com/profiles/company/465959-80


Leave a Comment